Incomplete excision of basal cell carcinoma (BCC) in the head and neck region: to wait, or not to wait?

Introduction Recurrence rates for incompletely excised basal cell carcinoma (BCC) vary widely in the literature. Clinical observation is a commonly accepted method of follow up, however such management of these lesions still remains controversial. Aim To evaluate the rate and factors associated with the recurrence of BCC of the head and neck region after incomplete excision. Material and methods Medical records of 135 patients with 156 incompletely excised BCCs of the head and neck region were analyzed retrospectively. The primary outcome was the rate of recurrence. Additionally, a correlation of recurrence to clinical and morphological factors was analyzed. Results Recurrence occurred in 72 (46%) lesions. The mean interval to recurrence was 20 months. In each category of factors, the highest relative risk of recurrence was correlated to: location on the scalp – 2.27, diameter over 2 cm – 1.21, nodular clinical form – 1.29, morpheaform histopathological type – 1.67, recurrent lesion – 1.88, irradicality of excision in the lateral margin – 1.24 and closure of the skin defect with the split-thickness skin graft – 1.42 relative risk. Conclusions Observation is an acceptable management option as less than a half of incompletely excised BCCs recurred and needed further treatment. As 85% of recurrences occur within 3 years after operation, clinical observation should be particularly careful during this period, however long-term recurrence should not be underestimated.

[1]  M. Cho,et al.  Scalp Basal Cell Carcinoma: Review of 2,202 Cases , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[2]  S. Sporny,et al.  Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid , 2016, Postepy dermatologii i alergologii.

[3]  W. Sterry Guidelines: the management of basal cell carcinoma. , 2006, European journal of dermatology : EJD.

[4]  J. Lear,et al.  Prognostic factors for a subsequent basal cell carcinoma: implications for follow‐up , 2006, The British journal of dermatology.

[5]  J. Bonnetblanc,et al.  Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions , 2004, The British journal of dermatology.

[6]  Conway C. Huang,et al.  Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. , 2004, Seminars in cutaneous medicine and surgery.

[7]  J. Townend,et al.  Surgical management of incompletely excised basal cell carcinomas of the head and neck. , 2004, The British journal of oral & maxillofacial surgery.

[8]  M. Earley,et al.  The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. , 2003, Irish medical journal.

[9]  D. Kuijpers,et al.  Basal Cell Carcinoma , 2002, American journal of clinical dermatology.

[10]  R. Stern,et al.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. , 2000, Archives of dermatology.

[11]  R. Griffiths,et al.  Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision. , 1999, British journal of plastic surgery.

[12]  M. Strick,et al.  Basal cell carcinomas: do they need to be followed up? , 1994, Journal of the Royal College of Surgeons of Edinburgh.

[13]  C. Grin,et al.  Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. , 1992, The Journal of dermatologic surgery and oncology.

[14]  R. Kirsner,et al.  The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma. , 1992, Journal of the American Academy of Dermatology.

[15]  Fei Liu,et al.  A management approach to incompletely excised basal cell carcinomas of skin. , 1991, International journal of radiation oncology, biology, physics.

[16]  R. Carroll,et al.  Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. , 1989, The Journal of dermatologic surgery and oncology.

[17]  J. Zitelli,et al.  Surgical margins for basal cell carcinoma. , 1987, Archives of dermatology.

[18]  A. Lee Dellon,et al.  Recurrence rate of positive margin basal cell carcinoma: Results of a five‐year prospective study , 1985, Journal of surgical oncology.

[19]  S. Salasche,et al.  Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. , 1981, The Journal of dermatologic surgery and oncology.